tetano
Editor, Senior Moderator
World J Virol
. 2022 Jan 25;11(1):1-19.
doi: 10.5501/wjv.v11.i1.1.
Heart failure in COVID-19 patients: Critical care experience
Kevin John John[SUP] 1 [/SUP], Ajay K Mishra[SUP] 2 [/SUP], Chidambaram Ramasamy[SUP] 2 [/SUP], Anu A George[SUP] 2 [/SUP], Vijairam Selvaraj[SUP] 3 [/SUP], Amos Lal[SUP] 4 [/SUP]
Affiliations
Abstract
Patients with heart failure (HF) may be at a higher risk of coronavirus disease 2019 (COVID-19) infection and may have a worse outcome due to their comorbid conditions and advanced age. In this narrative review, we aim to study the interaction between COVID-19 and HF from a critical care perspective. We performed a systematic search for studies that reported HF and critical care-related outcomes in COVID-19 patients in the PubMed and Medline databases. From a total of 1050 papers, we identified 26 that satisfied the eligibility criteria for our review. Data such as patient demographics, HF, intensive care unit (ICU) admission, management, and outcome were extracted from these studies and analyzed. We reported outcomes in heart-transplant patients with COVID-19 separately. In hospitalized patients with COVID-19, the prevalence of HF varied between 4% and 21%. The requirement for ICU admission was between 8% and 33%. HF patients with COVID-19 had an overall mortality rate between 20% and 40%. We identified that HF is an independent predictor of mortality in hospitalized COVID-19 patients, and patients with HF were more likely to require ventilation, ICU admission and develop complications. Patients with HF with reduced ejection fraction did worse than those with HF with midrange ejection fraction, and HF with preserved ejection fraction. COVID-19 patients with HF should be identified early and managed aggressively in an attempt to improve outcomes in this cohort of patients.
Keywords: COVID-19; Critical care; Heart failure; Intensive care; Mortality.
. 2022 Jan 25;11(1):1-19.
doi: 10.5501/wjv.v11.i1.1.
Heart failure in COVID-19 patients: Critical care experience
Kevin John John[SUP] 1 [/SUP], Ajay K Mishra[SUP] 2 [/SUP], Chidambaram Ramasamy[SUP] 2 [/SUP], Anu A George[SUP] 2 [/SUP], Vijairam Selvaraj[SUP] 3 [/SUP], Amos Lal[SUP] 4 [/SUP]
Affiliations
- PMID: 35117968
- PMCID: PMC8788216
- DOI: 10.5501/wjv.v11.i1.1
Abstract
Patients with heart failure (HF) may be at a higher risk of coronavirus disease 2019 (COVID-19) infection and may have a worse outcome due to their comorbid conditions and advanced age. In this narrative review, we aim to study the interaction between COVID-19 and HF from a critical care perspective. We performed a systematic search for studies that reported HF and critical care-related outcomes in COVID-19 patients in the PubMed and Medline databases. From a total of 1050 papers, we identified 26 that satisfied the eligibility criteria for our review. Data such as patient demographics, HF, intensive care unit (ICU) admission, management, and outcome were extracted from these studies and analyzed. We reported outcomes in heart-transplant patients with COVID-19 separately. In hospitalized patients with COVID-19, the prevalence of HF varied between 4% and 21%. The requirement for ICU admission was between 8% and 33%. HF patients with COVID-19 had an overall mortality rate between 20% and 40%. We identified that HF is an independent predictor of mortality in hospitalized COVID-19 patients, and patients with HF were more likely to require ventilation, ICU admission and develop complications. Patients with HF with reduced ejection fraction did worse than those with HF with midrange ejection fraction, and HF with preserved ejection fraction. COVID-19 patients with HF should be identified early and managed aggressively in an attempt to improve outcomes in this cohort of patients.
Keywords: COVID-19; Critical care; Heart failure; Intensive care; Mortality.